AI adoption

Government regulation can slow health systems' AI progress; Ed Marx, Marx Advisory CEO, says showing policymakers AI's real-world benefits in person can help them understand its value more than traditional lobbying.

If organizations are more transparent with clinicians and patients about AI adoption and deployment, stakeholders would feel more secure with it, says Nicole Ramage, senior market insights manager at HIMSS.

Also, See-Mode has received the first US FDA approval for a thyroid ultrasound analysis AI solution.

Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.

The solution answers common questions about COVID-19 in Welsh or English.  

AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.